Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kouki Fujikawa"'
Autor:
Toshiya Hiroyoshi, Kouki Fujikawa, Yuki Nakayama, Kimihiko Nakamura, Naohito Isoyama, Hideyasu Matsuyama
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Cardiovascular disease (CVD) is a major cause of mortality in patients with chronic kidney disease (CKD). Renal ischemia-reperfusion injury (IRI) is a clinically significant condition that progress to CKD after acute kidney injury
Autor:
Toshiya Hiroyoshi, Kouki Fujikawa, Kimihiko Nakamura, Naohito Isoyama, Hideyasu Matsuyama, Yuki Nakayama
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Renal ischemia-reperfusion injury (IRI) is a clinically significant condition that leads to acute kidney injury (AKI). AKI is followed by tissue repair characterized by collagen deposition and fibrosis which ultimately results in
Autor:
Hideyasu Matsuyama, Makoto Kuro-o, Toshiya Hiroyoshi, Naohito Isoyama, Kouki Fujikawa, Kimihiko Nakamura, Yuki Nakayama
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Serum calciprotein particles (CPP) are increased in CKD patients and correlated with vascular stiffness and calcification. CPPs are can be distinguished amorphous and crystal CPPs. Crystal CPPs are non-incubated CPPs and amorphous
Autor:
Sheuli, Afroz, Ayano, Yagi, Kouki, Fujikawa, M Motiur, Rahman, Katsuya, Morito, Tatsuya, Fukuta, Shiro, Watanabe, Emi, Kiyokage, Kazunori, Toida, Taro, Shimizu, Tatsuhiro, Ishida, Kentaro, Kogure, Akira, Tokumura, Tamotsu, Tanaka
Publikováno v:
Prostaglandinsother lipid mediators. 135
Lysophosphatidic acid (LPA) is a bioactive phospholipid that induces diverse biological responses. Recently, we found that LPA ameliorates NSAIDs-induced gastric ulcer in mice. Here, we quantified LPA in 21 medicinal herbs used for treatment of gastr